Q&A: Demis Hassabis talks 'turbocharging' Isomorphic with $600M, expanding into antibodies and the US April 1, 2025 By admin Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into biologics/antibodies.
